Aurobindo Pharma reported INR617.54B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Cipla INR 434.34B 9.38B Sep/2026
Divis Laboratories Ltd INR 219.64B 19.31B Sep/2026
Dr.Reddys Laboratories INR 576.31B 1.01B Sep/2026
Hindustan Unilever INR 829.07B 31.55B Sep/2026
Sun Pharmaceuticals INR 1.15T 60.53B Sep/2026
UPL INR 1.01T 58.17B Sep/2026